Evidence map›Paper›PMID 22987310›Full record

ReviewJournal of cardiovascular translational research2012

The origin and arrhythmogenic potential of fibroblasts in cardiac disease.

Carolina Vasquez, Gregory E Morley

Abstract readReview
In one paragraph

Review in Journal of cardiovascular translational research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. CaBritish journal of pharmacology · 2020
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Myocardial fibrosis in congenital and pediatric heart disease.Experimental and therapeutic medicine · 2017
    Article
  17. Review
  18. Review
  19. Article
  20. Cardiac applications of optogenetics.Progress in biophysics and molecular biology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Carolina VasquezLeon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, 522 First Avenue, Smilow Building 8th Floor, New York, NY 10016, USA.
Gregory E Morley
New York University · US

Funding

Training Program in Cardiovascular SciencesT32HL098129 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Glenn I Fishman, Ira J Goldberg · 2009 to 2026
$5.9M
Intercellular Communication and Cardiac ArrhythmiasR01HL076751 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MORLEY, GREGORY E · 2005 to 2017
$5.6M
NHLBI NIH HHS HL076751NHLBI NIH HHS R01 HL076751NHLBI NIH HHS T32 HL098129
6 · The paper itself

Abstract

Fibroblasts play a major role in normal cardiac physiology and in the response of the heart to injury and disease. Cardiac electrophysiological research has primarily focused on the mechanisms of remodeling that accompany cardiac disease with an emphasis on myocyte electrophysiology. Recently, there has been increasing interest in the potential role of fibroblasts in cardiac electrophysiology. This review focuses on the arrhythmia mechanisms involving interactions between myocytes and fibroblasts. We also discuss the available evidence supporting the contribution of intracardiac and extracardiac sources to the fibroblast and myofibroblast populations in diseased hearts.

Indexed as

Cell DifferentiationCell LineageAction PotentialsAnimalsArrhythmias, CardiacCell CommunicationEpithelial-Mesenchymal TransitionFibroblastsHumansMyocytes, CardiacMyofibroblastsSignal Transduction

Identifiers

PMID22987310
PMCPMC3666853
OpenAlexW1989807868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.